News, insight, events and case studies
-
Insight
5 Ways to Improve POCT ROI
Kim Futrell, MT(ASCP), MSHI Get more benefits from your point-of-care testing (POCT) program The advantage of quick test results to enable faster clinical decisions is one of the major reasons to implement point-of-care testing (POCT). At a time when hospitals and laboratories are under intense pressure, the benefits of patients accessing tests outside the traditional […]
30 August 2021
-
Report
The Rise of Molecular Point-of-Care Testing
Molecular, Point-of-Care Abstract Point-of-care testing (POCT) technology continues to advance at a fast pace, making it easier to shrink complex testing platforms into point-of-care (POC) devices. By testing at a molecular level, the accuracy of the results far surpasses previous POCT methodologies. Molecular POCT devices allow quick, easy-to-use testing in near-patient scenarios where a rapid […]
-
Case study
SI-DEP project France
As part of the pandemic management in France, detecting and tracing Covid-19 cases is critical for a successful recovery from the crisis and the protection of the French people. This is the purpose of the national SI-DEP (Système d’Informations de DEPistage) project implemented by the French Ministry of Health and Solidarity, which selected and commissioned CliniSys | MIPS, in partnership with the AP-HP hospital group, for this task. The CyberLab electronic order entry and result consultation system is at the heart of SI-DEP’s IT platform.
-
Events - Past
TOPICS FROM THE BENCH
JULY 14TH AT 2:00 P.M. ET WHERE DOES ALL THE LAB WASTE GO?14 July 2021
Where Does All The Laboratory Waste Go? Paul Canevaro from U.S. Ecology (https://www.usecology.com/) will discuss the mechanisms and procedures for the handling of laboratory waste. This talk will speak to the waste classification, handling and final disposal, whether through landfill or incinerations. About US Ecology: US Ecology services a wide range of companies nationwide who […]
-
Insight
COVID-19 Diagnostic Testing — Moving to the Point-of-Care: Part 2 in a Series
In our Part 1 of this blog series, we discussed the changes we are anticipating in the centralized testing model for COVID-19. There are some changes in store for the COVID-19 diagnostics market driven by the increase in the number of recent authorizations by the US Food and Drug Administration (FDA) for point-of-care (and point of need) […]
17 June 2021
-
Insight
The Changing Landscape of COVID-19 — What’s Next? Part 1 in a Series
The United States is reaching a transition point in the COVID-19 pandemic due to a rise in the SARS-CoV-2-immune population (via vaccination or infection) and the onset of warmer weather. As a result, the COVID-19 cases in the United States are expected to decrease over the next few months. However, this year’s autumn and winter […]
9 June 2021
-
News
CliniSys Group creates single brand for UK and Europe
New identity for CliniSys and MIPS is launched with refreshed logo and updated website Move reflects 40-year history of delivering industry-leading, end-to-end solutions for customers paired with a commitment to future innovation.
26 March 2021
-
Insight
New look, same values, renewed commitment to innovation
CliniSys Group has created a single brand for the UK and Europe, with a new website, color palette and logo. What does it all mean for us, our customers and business partners? Michael Simpson, Group Chief Executive Officer explains. Hello and welcome to the new CliniSys | MIPS website! A single name brand for CliniSys […]
18 March 2021
-
Insight
What Labs Need to Know about the Biden COVID-19 Response Plan
In February, the Biden administration released its National Strategy for the COVID-19 Response and Pandemic Preparedness, which outlines seven goals that address a domestic response and global response to the current COVID-19 pandemic and prepare for future health-related threats. Foundationally, the plan’s goals revolve around establishing a science-based approach to countermeasures against the COVID-19 pandemic that […]
9 March 2021
-
Insight
‘Joining the dots’ at CliniSys
In its simplest form at CliniSys, it is about ‘joining the dots’ and bringing the organisation together as one powerful brand and voice. Marketing planning is already underway and starting in the first quarter of 2021 there will be a series of initiatives to support the CliniSys Group’s marketing and corporate goals.
15 January 2021
-
Case study
Isala Hospital, Zwolle, the Netherlands
Quality time: Dutch clinical chemistry lab uses CyberLab to support hospital’s quality accreditation and commitment to patient care in daily practice
-
Case study
AZ Sint-Jan Brugge-Oostende, Belgium, CyberLab, CyberTrack
Digitisation of order entry and blood transfusion management at the bedside and beyond, improves efficiency and leads to greater patient safety.